Health
EMA recommends approval of six medicines, expands indications for nine
EMA’s human medicines committee (CHMP) published the outcomes of their meeting on Friday (30 January). EMA recommended six medicines for approval at its meeting and extended the therapeutic indications of nine medicines.
Here are some highlights:
Menopause: The committee recommended marketing authorisation for Fylrevy (estetrol), a hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal women who have had a hysterectomy, made by Hungarian company Gedeon Richter Plc.
GR’s Head of Women’s Healthcare (WHC), Dr Péter Turek, Business Unit, said that it was an important milestone, saying it may be the first innovative hormonal therapy for menopause in the European market in decades.
“Bringing an original product to the market – our second, based on the unique, proprietary Estetrol platform – would be a major achievement for Richter. It reflects our unwavering commitment to improving the quality of life of women globally, validates our strategy to invest in original research, and further strengthens our leading position in Europe.”
Cancer: Use of Zynyz in the treatment...
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Buying property in Thailand? Experts say these are the tax misunderstandings to look out for
Examining Angola’s pragmatic path to energy security and low-carbon growth
Iran’s democratic horizon: Europe’s turning point and the power of the third option
AJC welcomes overdue EU designation of IRGC as terror organization
Some 100,000 expected at free-Iran mass rally in Berlin in solidarity with nationwide uprising
Bangladesh heads to the polls as minorities face an uncertain future
Expats may fall outside UK inheritance tax after 10 years abroad under new rules, expert says
OECD urges faster access and better use of resources in cancer care
Russian yogurt appears in American athlete’s Olympic Village room tour
Swiss-based packaging manufacturer Amcor returns to Russia after 2022 exit, says local media
Uzbekistan-China: Exemplary partnership
Fifty groups present demand for a new approach to women’s health
Restoring wetlands with LIFE Programme's biggest project so far
Great sights and great dining...the things Cambridge and Venice share in common
EU reaffirms commitment to science-based multilateralism at first plenary on chemicals, waste and pollution
New strategies on migration and EU visa make borders more secure and encourage talent mobility
Japan should face up to history and contribute more to regional peace
Ambassador calls for 'speeding up' of co-operation between EU and Kazakhstan
Timur Turlov at Smart Moves Summit 2025: How chess can transform global education
Shevtsova’s case: Out-of-court sanctions dismantling trust in Ukrainian cause
The future of European transport
Trump Vs Trueman
US 'no longer' an 'unconditional ally' for Europe - MEP
MEP warns tariffs could cause 'huge disruption'
-
Taxation5 days agoBuying property in Thailand? Experts say these are the tax misunderstandings to look out for
-
Angola5 days agoExamining Angola’s pragmatic path to energy security and low-carbon growth
-
Iran5 days agoIran’s democratic horizon: Europe’s turning point and the power of the third option
-
General5 days agoAJC welcomes overdue EU designation of IRGC as terror organization